INFLECTRA

This brand name is authorized in United States. It is also authorized in Albania, Australia, Austria, Canada, Croatia, Cyprus, Estonia, Finland, France, Germany, Ireland, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Spain, UK.

Active ingredients

The drug INFLECTRA contains one active pharmaceutical ingredient (API):

1	Infliximab UNII B72HH48FLU - INFLIXIMAB
	Infliximab is a chimeric human-murine monoclonal antibody that binds with high affinity to both soluble and transmembrane forms of TNFα but not to lymphotoxin α (TNFβ).
	Read more about Infliximab

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
INFLECTRA Powder for solution for infusion	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L04AB02	Infliximab	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AB Tumor necrosis factor alpha (TNF-α) inhibitors
Discover more medicines within L04AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	631/96
AU	Pharmaceutical Benefits Scheme	10057H, 10067W, 10184B, 10196P, 11389K, 11396T, 11399Y, 11400B, 11412P, 11423F, 11424G, 11432Q, 11445J, 11448M, 11449N, 11450P, 11459D, 11461F, 11481G, 11482H, 11483J, 11486M, 11487N, 11488P, 11489Q, 11490R, 11497D, 11498E, 11514B, 11515C, 11590B, 11595G, 11605T, 11606W, 11796W, 11797X, 5753T, 5754W, 5755X, 5756Y, 5757B, 5758C, 6397Q, 6448J, 6496X, 9612X, 9613Y, 9617E, 9654D, 9674E
CA	Health Products and Food Branch	02419475
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	05702617, 06575061, 08798546, 10315704, 10315710, 10315727, 10315733, 10315756, 11144179, 11144191, 11144222, 11144245, 11155869, 11155875, 11155906, 11155912, 11155929, 11174128, 11174140, 11174157, 11174163, 11217300, 11217317, 11217323, 11217346, 11217352, 11344961, 11532243, 11532266, 11532272, 11649169, 11649181, 11649198, 11649206, 11668020, 12389084, 12531932, 12727931, 12728221, 12774132, 13333625, 13704091, 13753333, 13753356, 13753362, 13753379, 13753385, 13837544, 13892477, 13892566, 14277716, 14277722, 14341360, 14341408, 15267418, 15267424, 15267430, 15267447, 15389972, 15389989, 15389995, 15390001, 15390018, 15434017, 15434023, 15434046, 15434052, 15434069, 16209914, 16370058, 16370064, 16370070, 16370087, 16370093, 16585818, 16743803, 16743826, 16743832, 17180437, 17180466, 17312583
EE	Ravimiamet	1624878, 1624889, 1624890, 1624902, 1665907
ES	Centro de información online de medicamentos de la AEMPS	113854001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	456703
FR	Base de données publique des médicaments	61467125
GB	Medicines & Healthcare Products Regulatory Agency	289433
IT	Agenzia del Farmaco	043010014, 043010026, 043010038, 043010040, 043010053
LT	Valstybinė vaistų kontrolės tarnyba	1071198, 1071199, 1071200, 1071201, 1071202
NL	Z-Index G-Standaard, PRK	54542
NZ	Medicines and Medical Devices Safety Authority	16219
PL	Rejestru Produktów Leczniczych	100270720
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64826001, W64826002, W64826003, W64826004, W64826005
US	FDA, National Drug Code	0069-0809